1. Home
  2. CD22
  3. Anti-CD22 scFv h(CD4-FcεRIγ) CART, pCDCAR1

pCDCAR1 CD22 h(4γ), T(CAR-T-2-M308-4G)

DatasheetDatasheet

Online Inquiry

The vector of anti-CD22 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human CD22. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-CD22 antibody linked to CD4 transmembrane domain and FcεRIγ signaling domains. And the vector product was designed for the treatment of acute lymphoblastic leukemia (ALL) .

Details

Target
CD22
Target Species
Human
Targeting Cell Type
T cell
Targeting Diseases
Acute lymphoblastic leukemia (ALL)
Generation
Second
Vector Name
pCDCAR1
Vector Length
8kb
Vector Type
Lentiviral
Receptor Construction
scFv-CD4-FcεRIγ
Discription of Signaling Cassetes
CD4
Cluster of Differentiation 4 (CD4) is a glycoprotein expressed on the surface of T helper cells, regulatory T cells, monocytes, macrophages and dendritic cells, and plays an important role in the development and activation of T cells. On T cells, CD4 is the co-receptor for the T cell receptor (TCR), and these two distinct structures recognize the Antigen-Major Histocompatibility Complex (MHC). CD4 signaling in CAR ensures specificity of the TCR-antigen interaction, prolongs the contact between the T cell and the antigen presenting cell and recruits the tyrosine kinase Lck, which is essential for T cell activation.
FcεRIγ
The high-affinity IgE receptor, also known as FcεRI, or Fc epsilon RI, is the high-affinity receptor for the Fc region of immunoglobulin E (IgE). FcεRI is a key molecule involved in allergic reactions. It is a tetramer composed of 1alpha, 1 beta, and 2 gamma chains. The gamma chains are also subunits of other Fc receptors. The scFv-based CARs engineered to contain a signaling domain from FcεRIγ have been shown to deliver a potent signal for T cell activation and function.
Antibody Clone
FMC63
Antibody Host
Mouse

Target

Gene Name
CD22 molecule
Official Symbol
CD22
Gene ID
933
Synonyms
CD22; CD22 molecule; SIGLEC2; SIGLEC-2; acute lymphoblastic leukemia; leukemia; ALL; scFv; FcεRIγ; Chimeric antigen receptor; T cell; Retrovirus; CARs; Lentivirus; chimeric T cell receptors; chimeric immunoreceptors; chimeric antigen receptors; FMC63

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Cat# Description
VP-CAR-LC82 Lenti-CD22 CAR (scFv-b2c-CD3ζ, FMC63) Viral Particle
CAR-LC159 Anti-CD22 (m971) h(CD28-41BB-CD3ζ) CAR, pCDCAR1
VP-CAR-LC84 Lenti-CD22 CAR (scFv-CD28-OX40-CD3ζ, FMC63) Viral Particle
VP-CAR-LC551 Lenti-CD22 CAR (scFv-CD28-41BB-CD3ζ, HA22) Viral Particle
CAR-LC065 Anti-CD22 (BL22) h(CD28-41BB-CD3ζ) CAR, pCDCAR1
VP-CAR-LC77 Lenti-CD22 CAR (scFv-CD28-CD3ζ, FMC63) Viral Particle
VP-CAR-LC643 Lenti-CD22 CAR (scFv-CD28-41BB-CD3ζ, m971) Viral Particle
VP-CAR-LC641 Lenti-CD22 CAR (scFv-41BB-CD3ζ, m971) Viral Particle
VP-CAR-LC552 Lenti-CD22 CAR (scFv-41BB-CD3ζ, HA22) Viral Particle
VP-CAR-LC81 Lenti-CD22 CAR (scFv-41BB-CD3ζ, FMC63) Viral Particle

Leukemia Kits for CARs/TCRs Development 

Online Inquiry

Name:
* Phone:
*E-mail Address:
*Service & Products Interested:
Project Description:
*Verification Code:
Please input "biolabs"(case insensitive) as verification code.
CB Promise
CONTACT US
45-1 Ramsey Road, Shirley, NY 11967, USA
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356
Email:
CONTACT US

USA
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

Europe
Ringstrasse 4, 64401 Gross-Bieberau, Germany
Tel: 44-207-097-1828

Distributors

To view the contact information for a specific location, select your country or region:

Australia
australia

FOLLOW US ON

Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved